Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 1 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 12428489

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  2. US 12420113

    Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy

    The Board of Regents of the University of Texas System · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  3. US 12419811

    Hydrogel drug delivery composition

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  4. US 12422364

    Fluorescence spectral shape analysis for analyte recognition

    The Board of Regents of the University of Texas System · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  5. US 12419942

    Use of the Salmonella spp type III secretion proteins as a protective vaccination

    The Board of Regents for Oklahoma State University · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  6. US 12415867

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  7. US 12410209

    Modified glucocorticoids

    The Board of Regents of the University of Texas System · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  8. US 12410232

    Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor

    The Board of Regents of the University of Texas System · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  9. US 12410231

    Natural killer cell products and methods

    The Board of Regents of the University of Texas System · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  10. US 12404347

    Glucuronoxylomannan (GXM) receptor chimeric antigen receptors and use thereof

    The Board of Regents of the University of Texas System · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  11. US 12403093

    Methods for production of MSC-derived exosomes

    The Board of Regents of the University of Texas System · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted
  12. US 12396988

    Methods of using muscarinic antagonists in the treatment of depression

    The Board of Regents of the University of Texas System · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  13. US 12398375

    Methods for improved poxvirus yields

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  14. US 12390483

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  15. US 12383629

    DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  16. US 12383652

    Nanofiber structures and methods of manufacture and use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  17. US 12383627

    Antimicrobial scaffolds

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  18. US 12383538

    Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer

    The Board of Regents of the University of Texas System · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  19. US 12383518

    Disulfide-masked pro-chelator compositions and methods of use

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  20. US 12378201

    Histone demethylase inhibitors for treating cancers

    The Board of Regents of the University of Texas System · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  21. US 12377191

    Chondroinductive peptides and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  22. US 12377186

    Antimicrobial biopolymer compositions, methods of synthesis, and applications of use

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  23. US 12365664

    Small molecule inhibitors of SRC tyrosine kinase

    The Board of Regents of the University of Texas System · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  24. US 12365761

    Biodegradable ultra-pH sensitive polymers

    The Board of Regents of the University of Texas System · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted